Smith & Nephew Overview
- Year Founded
-
1855
- Status
-
Public
- Employees
-
17,000
- Stock Symbol
-
SN.
- Investments
-
57
- Share Price
-
$15.53
- (As of Thursday Closing)
Smith & Nephew General Information
Description
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 40% of the UK-based firm's revenue comes from orthopedic products, and another 31% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the US, just over 30% is from other developed markets, and emerging markets account for the remainder.
Contact Information
Website
www.smith-nephew.comCorporate Office
- Building 5, Croxley Park
- Hatters Lane
- Watford WD18 8YE
- England, United Kingdom
Corporate Office
- Building 5, Croxley Park
- Hatters Lane
- Watford WD18 8YE
- England, United Kingdom
Smith & Nephew Timeline
Smith & Nephew Stock Performance
As of 12-Nov-2026, Smith & Nephew’s stock price is $15.53. Its current market cap is $13B with 837M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.53 | $15.41 | $12.95 - $18.64 | $13B | 837M | 3.03M | $0.74 |
Smith & Nephew Financials Summary
As of 30-Jun-2026, Smith & Nephew has a trailing 12-month revenue of $6.3B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 14,938,941 | 16,882,999 | 13,909,937 | 14,868,961 |
| Revenue | 6,300,000 | 6,164,000 | 5,810,000 | 5,549,000 |
| EBITDA | 1,550,000 | 1,504,000 | 1,197,000 | 922,000 |
| Net Income | 635,000 | 625,000 | 412,000 | 263,000 |
| Total Assets | 11,013,000 | 10,457,000 | 10,354,000 | 9,987,000 |
| Total Debt | 3,785,000 | 3,327,000 | 3,321,000 | 3,084,000 |
Smith & Nephew Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Smith & Nephew Comparisons
Industry
Financing
Details
Smith & Nephew Competitors (26)
One of Smith & Nephew’s 26 competitors is Globus Medical, a Formerly VC-backed company based in Audubon, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Globus Medical | Formerly VC-backed | Audubon, PA | ||||
| Medtronic | Corporation | Minneapolis, MN | ||||
| Orthofix Medical | Formerly PE-Backed | Lewisville, TX | ||||
| Coloplast | Corporation | Humlebaek, Denmark | ||||
| Aspen Surgical Products | Private Equity-Backed | Caledonia, MI |
Smith & Nephew Patents
Smith & Nephew Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024213613-A1 | Wound dressing | Inactive | 12-Apr-2023 | ||
| WO-2024213614-A1 | Wound dressing | Inactive | 12-Apr-2023 | ||
| WO-2024208790-A1 | Printed circuit board configurations for negative pressure wound therapy devices | Inactive | 03-Apr-2023 | ||
| WO-2024200195-A1 | Reduction of false alarms during provision of negative pressure wound therapy | Inactive | 27-Mar-2023 | ||
| WO-2024160760-A1 | Negative pressure wound therapy devices and methods utilizing a turbine | Inactive | 31-Jan-2023 | A61M1/982 |
Smith & Nephew Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Smith & Nephew Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Smith & Nephew Investments & Acquisitions (57)
Smith & Nephew’s most recent deal was a Merger/Acquisition with Integrity Orthopaedics for . The deal was made on 21-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Integrity Orthopaedics | 21-Jan-2026 | Merger/Acquisition | Surgical Devices | ||
| BEAR Implant | 02-Apr-2024 | Later Stage VC | Therapeutic Devices | ||
| CartiHeal | 09-Jan-2024 | Merger/Acquisition | Therapeutic Devices | ||
| Additive Instruments | 09-Mar-2023 | Merger/Acquisition | Surgical Devices | ||
| Pivot Medical | 01-Jan-2023 | Merger/Acquisition | Surgical Devices |
Smith & Nephew ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
19.7 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Smith & Nephew Exits (4)
Smith & Nephew’s most recent exit was on 01-Dec-2016 from OrthoSpace. The exit was categorized as with 4 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| OrthoSpace | 01-Dec-2016 | Completed |
|
||
| OrthoSpace | 19-May-2015 | Completed |
|
||
| BSN medical | 01-Apr-2001 | Completed |
|
||
| Jobskin Australia | 01-Jan-1991 | Merger/Acquisition | Completed |
Smith & Nephew Affiliates
Subsidiaries (17)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| SERDA Therapeutics | Amsterdam, Netherlands | 2020 | |
| Integrity Orthopaedics | Maple Plain, MN | 2020 | |
| Additive Instruments | Watford, United Kingdom | 2019 | |
| CartiHeal | Kfar Saba, Israel | 2009 | |
| Klaus Peter Kunkelmann Und Ralph Kunkelmann Verwaltungsgesellschaft mbH | Bad Konig, Germany | 2005 |
Smith & Nephew FAQs
-
When was Smith & Nephew founded?
Smith & Nephew was founded in 1855.
-
Where is Smith & Nephew headquartered?
Smith & Nephew is headquartered in Watford, United Kingdom.
-
What is the size of Smith & Nephew?
Smith & Nephew has 17,000 total employees.
-
What industry is Smith & Nephew in?
Smith & Nephew’s primary industry is Medical Supplies.
-
Is Smith & Nephew a private or public company?
Smith & Nephew is a Public company.
-
What is Smith & Nephew’s stock symbol?
The ticker symbol for Smith & Nephew is SN..
-
What is the current stock price of Smith & Nephew?
As of 12-Nov-2026 the stock price of Smith & Nephew is $15.53.
-
What is the current market cap of Smith & Nephew?
The current market capitalization of Smith & Nephew is $13B.
-
What is Smith & Nephew’s current revenue?
The trailing twelve month revenue for Smith & Nephew is $6.3B.
-
Who are Smith & Nephew’s competitors?
Globus Medical, Medtronic, Orthofix Medical, Coloplast, and Aspen Surgical Products are some of the 26 competitors of Smith & Nephew.
-
What is Smith & Nephew’s annual earnings per share (EPS)?
Smith & Nephew’s EPS for 12 months was $0.74.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
